Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference5%
- Check19 days agoChange DetectedThe page replaces some drug-safety topic links with a new version label (v3.1.0 added) and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Substandard Drugs, and the earlier Revision v3.0.2).SummaryDifference0.7%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' link was removed. This reflects a straightforward release update with a minor UI cleanup.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has added significant information regarding drug safety, including specific drug names and locations in Hong Kong and Thailand, while removing various disease-related terms and previous location references.SummaryDifference12%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check68 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.